Cholesterol Insights
Peter discusses the significant role of PCSK9 in cholesterol management and its impact on heart disease. He highlights the stark contrast between individuals with high and low LDL levels and their susceptibility to cardiovascular issues. The conversation also touches on the lack of public awareness regarding ApoB and the potential benefits of medications like statins for longevity.In this clip
From this podcast
Huberman Lab
Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85
Related Questions
How do PCSK9 inhibitors reduce apoB in the context of the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Cholesterol Insights from the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Cholesterol Insights in the context of the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?